Chemotherapy use in Triplet approach for Metastatic Hormone-Sensitive Prostate Cancer: French Practice Survey and Expert Opinion
{{output}}
Introduction: Triplet therapy, combining androgen deprivation therapy (ADT) with docetaxel and either darolutamide or abiraterone/prednisone, has significantly improved outcomes in metastatic hormone-sensitive prostate cancer (mH... ...
